Article Details

SOLO1: Olaparib Maintenance Continues to Provide Clinical Benefit at 7 Years

Retrieved on: 2022-09-10 16:40:15

Tags for this article:

Click the tags to see associated articles and topics

SOLO1: Olaparib Maintenance Continues to Provide Clinical Benefit at 7 Years. View article details on HISWAI: https://www.cancertherapyadvisor.com/home/news/conference-coverage/esmo-2022/brca-clinical-benefit-olaparib-maintenance-therapy-treatment-risk-solo1/

Excerpt

... the use of olaparib maintenance in these patients to achieve long-term remission ... Resilience and Stress Management Program Aids Health Care ...

Article found on: www.cancertherapyadvisor.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up